Impact of Big Data Analytics on People’s Health: Overview of Systematic Reviews and Recommendations for Future Studies

Abstract

Background Although the potential of big data analytics for health care is well recognized, evidence is lacking on its effects on public health. Objective The aim of this study was to assess the impact of the use of big data analytics on people’s health based on the health indicators and core priorities in the World Health Organization (WHO) General Programme of Work 2019/2023 and the European Programme of Work (EPW), approved and adopted by its Member States, in addition to SARS-CoV-2–related studies. Furthermore, we sought to identify the most relevant challenges and opportunities of these tools with respect to people’s health. Methods Six databases (MEDLINE, Embase, Cochrane Database of Systematic Reviews via Cochrane Library, Web of Science, Scopus, and Epistemonikos) were searched from the inception date to September 21, 2020. Systematic reviews assessing the effects of big data analytics on health indicators were included. Two authors independently performed screening, selection, data extraction, and quality assessment using the AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews 2) checklist. Results The literature search initially yielded 185 records, 35 of which met the inclusion criteria, involving more than 5,000,000 patients. Most of the included studies used patient data collected from electronic health records, hospital information systems, private patient databases, and imaging datasets, and involved the use of big data analytics for noncommunicable diseases. “Probability of dying from any of cardiovascular, cancer, diabetes or chronic renal disease” and “suicide mortality rate” were the most commonly assessed health indicators and core priorities within the WHO General Programme of Work 2019/2023 and the EPW 2020/2025. Big data analytics have shown moderate to high accuracy for the diagnosis and prediction of complications of diabetes mellitus as well as for the diagnosis and classification of mental disorders; prediction of suicide attempts and behaviors; and the diagnosis, treatment, and prediction of important clinical outcomes of several chronic diseases. Confidence in the results was rated as “critically low” for 25 reviews, as “low” for 7 reviews, and as “moderate” for 3 reviews. The most frequently identified challenges were establishment of a well-designed and structured data source, and a secure, transparent, and standardized database for patient data. Conclusions Although the overall quality of included studies was limited, big data analytics has shown moderate to high accuracy for the diagnosis of certain diseases, improvement in managing chronic diseases, and support for prompt and real-time analyses of large sets of varied input data to diagnose and predict disease outcomes. Trial Registration International Prospective Register of Systematic Reviews (PROSPERO) CRD42020214048; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=214048

Using computer-assisted content analysis to advance anal dysplasia natural history research

“…To understand its natural history more accurately, we need big data analytics approaches leveraging enriched clinical and laboratory data from anal cancer screening programs [14]. Some limitations must be noted.…”

Process Improvement Approaches for Increasing the Response of Emergency Departments against the COVID-19 Pandemic: A Systematic Review

“…On the other hand, the big data analysis tool contains a set of complex data nested to the application of artificial intelligence algorithms and automated learning with high potential in ED healthcare. This is of fundamental support for health personnel in operations planning and implementation, decision making, disease detection, and other areas; thereby contributing to the increase in the quality of care provided in EDs and the intricate reduction of costs [34].…”

Predicting Patient-Level 3-Level Version of EQ-5D Index Scores From a Large International Database Using Machine Learning and Regression Methods

“…[6][7][8] Smart devices, big data, and advanced analytic techniques are contributing to the personalization of healthcare. [9][10][11][12][13] Nevertheless, because of varying rules of data sharing, standards of interoperability, available infrastructure or level of stakeholder collaboration, and data sets, which are usually collected at different time points for different purposes with different methods in the health data ecosystem, are difficult to connect. 14 For example, the Minimum European Health Module is a PRO measure collected regularly in Eurostat population surveys while hardly used in clinical trials.…”